OCGN: Ocugen, Inc. Stock

by  •  • Comments Off on OCGN: Ocugen, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 162.48
Enterprise Value ($M) 132.63
Book Value ($M) 29.63
Book Value / Share 0.10
Price / Book 5.48
NCAV ($M) 8.87
NCAV / Share 0.03
Price / NCAV 18.31

Profitability (mra)
Return on Invested Capital (ROIC) -0.87
Return on Assets (ROA) -0.84
Return on Equity (ROE) -1.33

Liquidity (mrq)
Quick Ratio 2.86
Current Ratio 2.86

Balance Sheet (mrq) ($M)
Current Assets 61.68
Assets 82.44
Liabilities 52.81
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 4.05
Operating Income -54.76
Net Income -54.05
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -42.14
Cash from Investing -3.38
Cash from Financing 64.86

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-05 13G State Street Corp 2.00 -62.93
11-12 13G/A Vanguard Group Inc 5.88 0.00
11-08 13G BlackRock, Inc. 6.50 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-05 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-04-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2024-04-16 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-11 2,020,510 4,252,044 47.52
2025-03-10 1,856,637 4,543,306 40.87
2025-03-07 1,366,734 2,788,876 49.01
2025-03-06 3,496,445 7,314,403 47.80

(click for more detail)

Similar Companies
NRXP – NRx Pharmaceuticals, Inc. NVCT – Nuvectis Pharma, Inc.
OCEA – Ocean Biomedical, Inc. OCX – OncoCyte Corporation
OKYO – OKYO Pharma Limited


Financial data and stock pages provided by
Fintel.io